Shareholders wishing to participate at the Annual General Meeting shall notify the company by mail to XVIVO Perfusion AB (publ), Box 53015, SE-400 14 Gothenburg, Sweden, Att: Catrin Olsson, by phone +46 31-788 21 53, by fax +46 31-788 21 69 or by e-mail catrin.olsson@xvivoperfusion.com. Name/business name, personal identification number/ company registration number (or the equivalent), address, telephone number, number of shares, details of any advisors and where appropriate details of a representative or proxy must be stated in the notification. A proxy form in Swedish for shareholders wishing to be represented by proxy will be found on www.xvivoperfusion.com.
Shareholders that have their shares registered in the name of a nominee must temporarily record their shares in the share register kept by Euroclear Sweden AB in their own names to be able to attend the General Meeting. Such registration must be carried out no later than Wednesday, April 23, 2014.
Attachment: Full notice (in Swedish)
March 28, 2014
Gothenburg
XVIVO Perfusion AB (publ)
The Board